Aflibercept

From Self-sufficiency
Jump to: navigation, search
Aflibercept
Systematic (IUPAC) name
Unable to be assigned
Identifiers
CAS Number 862111-32-8
ATC code none
Chemical data
Formula C4318H6788N1164O1304S32
Molar mass 96.90 kDa[[Script error: No such module "String".]]
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Aflibercept is a fusion protein under development for the treatment of cancer.

It functions as an inhibitor of vascular endothelial growth factor.[1][2]

Aflibercept is being co-developed by Sanofi-Aventis and Regeneron Pharmaceuticals. As of 2008, it is currently in phase III clinical trials.

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />


  1. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  2. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.